PATENT CLAIM ANALYSIS

Application Number: 16133977
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["607", "120000"]

Abstract:
Representative embodiments of the present invention provide for novel, minimally invasive implantable devices and methods for targeted tissue drug delivery of cardiovascular drugs.

Claim (Index 15):
A method of treating a patient suffering from an abnormal cardiac rhythm, the method comprising implanting a minimally invasive device, the device comprising:\n a. at least one inner catheter comprising an inner catheter conductor and at least one drug delivery channel located within the inner catheter; b. an outer catheter substantially surrounding the at least one inner catheter; and c. at least one electrically conductive element located at a substantially distal portion of the device, wherein the at least one electrically conductive element is adapted to provide defibrillation energy to a cardiac surface of the patient, wherein the distal portion of the device further comprises at least one drug release site for delivery of at least one drug to the cardiac surface of the patient.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.08696
- Patent Class: 607.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14427607', '10318298', '10679772', '11777283', '10608409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6757902949676842
- 35 USC 102 Novelty (BERT): 0.5725652183127162
- Combined Prediction Score: 0.6654677873021874
- Mean Citation Score: 283.585152
- Max Citation Score: 473.15042
- Similarity Product: 444.2040382828951

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test